Literature DB >> 30366917

Systematic review of interventions targeting sickness absence among pregnant women in healthcare settings and workplaces.

Pernille Pedersen1, Merete Labriola2, Claus Vinther Nielsen2, Rikke Damkjær Maimburg3,4, Ellen Aagaard Nohr5, Anne-Mette Momsen1.   

Abstract

OBJECTIVES: The high rate of sickness absence from work during pregnancy is recognised as a problem, and may be higher than necessary from a health perspective. The aim was to evaluate the effectiveness of interventions in healthcare settings and workplaces targeting sickness absence among pregnant women.
METHODS: Studies were eligible if they included pregnant women participating in any intervention in healthcare settings or workplaces. The outcome was length of sickness absence in days or number of episodes. Study design had to be either randomised controlled trials (RCTs) or quasi-experimental studies.The search for studies was conducted in PubMed, Scopus, CINAHL, PsycINFO, ClinicalTrials.gov and WHO trial registry. Risk of bias was assessed by the Joanna Briggs Institute standardised quality assessment instrument.
RESULTS: A total of nine studies were quality assessed and of these, four were excluded due to insufficient methodological quality. Five RCTs conducted in healthcare settings in Sweden and Norway were included. Due to heterogeneity, meta-analysis was not performed.Two RCTs examined complementary and alternative medicine and three RCTs the effect of physical exercise. In general, the frequency of women on sickness absence was lower in the intervention groups than the control groups, however, only among pregnant women who participated in a 12-week exercise programme, the frequency was significantly lower (22% vs 30%, p=0.04).
CONCLUSION: The evidence of interventions targeting sickness absence among pregnant women in healthcare settings is sparse, and no studies were conducted at workplaces.Future interventions including physical activity provided in collaboration with healthcare settings and workplaces are requested. Studies should measure sickness absence based on valid methods, measure compliance to the intervention and provide transparency of statistical methods. PROSPERO REGISTRATION NUMBER: CRD42018084802. © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  absenteeism; intervention; occupational exposure; pregnancy; sick leave

Mesh:

Year:  2018        PMID: 30366917      PMCID: PMC6224771          DOI: 10.1136/bmjopen-2018-024032

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


This review aimed to evaluate the effectiveness of interventions carried out in either healthcare settings or workplaces, and a quality assessment was performed using a standardised method. However, no studies conducted at workplaces were found. The five studies included were all conducted in Sweden and Norway; only one study of a 12-week exercise programme demonstrated a significantly reduced sickness absence frequency among pregnant women. The studies may be underpowered and not able to detect a difference in sickness absence. Future interventions need to explore the effect of physical activity on work maintenance, and be carried out in collaboration with healthcare settings and workplaces. Sickness absence as well as compliance with the intervention should be measured based on valid methods.

Introduction

Pregnant women may experience bodily changes as disabling and they consequently may be on sick leave from work.1–3 Sickness absence due to pregnancy may be higher than necessary from a health perspective4–6 and it is argued that pregnancy is being medicalised.7 The duration of sickness absence may be reduced by interventions aiming at work maintenance for pregnant women, thus, it is of importance to explore such interventions conducted in healthcare settings and workplaces. In Scandinavia, the rate of sickness absence among pregnant women is high compared with non-pregnant women.7–12 Thus, the average sickness absence is 8.5 days per year for all Danish employees13 compared with 48 days among pregnant women.14 In Norway, three out of four pregnant women were absent due to sickness for a median duration of 8 weeks.15 The average sickness absence during pregnancy has increased over the last decades.10 16–18 According to the literature, the main reasons for sickness absence during pregnancy are health related, for example, nausea/vomiting, fatigue, sleep disturbances, bleeding, pelvic pain and low back pain.12 15 19–21 Especially low back pain is frequent and increases the rate of sickness absence during pregnancy.22 Low back pain may also have impact on future work ability if rehabilitation is insufficient as the rate of relapse is high.22 23 General and health-related risk factors for sickness absence include multiparity, age, educational level, use of reproductive therapy, back pain, maternal weight and smoking habits.11 16 17 24–28 Physical activity on the other hand is associated with a lower risk of absence from work during pregnancy,24 25 maybe because it reduce pain and disability.22 Moreover, high maternal weight is a risk factor for low back pelvic pain.24 Thus, there seems to be a pathway from high maternal weight through low level of physical activity to sick leave during pregnancy. Pregnant women are therefore recommended to continue physical activity by healthcare professionals.29 Work-related risk factors include previous sickness absence, low job control, lifting, night or shift work,7 working in standing position and high job strain.30 However, except for high levels of exposure, such as working in night shift, >40 hours/week, lifting >100 kg/day, standing >6 hours/day, recent reviews do not provide strong evidence for mandatory restrictions of occupational factors, as risk of miscarriage and low birth weight are only moderately elevated.31–33 Thus, there is no reason to believe that common workplace exposures constitute a high risk for pregnant women.29 Moreover, job adjustment has been found to reduce sickness absence, but only few pregnant women obtain the needed adjustment.28 34 Sickness certificates may be needed if adjustments are not possible, for example, in hazardous jobs involving chemical procedures or biological risks. However, studies found that only 0.5%–5% of sickness certificates related to possible teratogenic effects.21 35 Sickness certificates are issued based on health-related reasons. However, medical explanations may not be the main reason for sickness absence during pregnancy. A study found that three out of four pregnant women on sickness absence rated their health as good or excellent.36 Moreover, comparison of sick-listed to not sick-listed pregnant women has not shown differences in either mode of delivery or birth weight.18 36 Thus, sickness absence may be a complex social phenomenon due to changes in attitudes towards the naturally occurring pregnancy discomforts as well as inexpedient coping strategies among pregnant women.19 20 37–39 Physicians might find it difficult to establish a medical diagnosis to support a sickness certificate and find themselves in a dilemma between being the woman’s confidante and preventing unnecessary sickness absence.4–6 Legislation and compensation rules vary across countries resulting in different rates of sickness absence.40 Thus, associations are found between higher social benefits and higher rates of sickness absence registered during pregnancy.36 37 Sickness absence during pregnancy has consequences for both the pregnant women and society. At the individual level, the consequences are loss of possibilities for a salary increase and promotions, and it may result in a contract not being renewed.41 Moreover, long-term sickness absence is a predictor for future sickness absence and for receiving disability pension 8 years after child birth.25 For workplaces and society, sickness absence results in considerable costs due to reduced productivity; pregnancy-related sickness absence constituted around 4000 full-time positions corresponding to an annual cost of Kr1.4 billion.14 Moreover, employers may become reluctant to employing women of childbearing age.21 41 A literature review exploring pregnancy at workplaces recommends an improvement of the workplace conditions, for example, social support and a proactive approach.33 In order to sustain the ability to work for pregnant women recommendations are made to support a healthy work environment by eliminating risks and hazards.42 43 Several current laws within the USA, Canada, the UK and the European Union (EU) are in force to delineate the rights of pregnant women.33 However, an initial search found only few interventions conducted in healthcare settings to reduce sickness absence; the studies were of low quality and results were inconclusive.44 45 The literature illustrates the potential for preventive initiatives in both healthcare settings and workplaces among pregnant women. A search in the databases PROSPERO, PubMed, the Cochrane Library and the JBI Database of Systematic Reviews and Implementation Reports did not result in retrieving any systematic reviews or protocols on sickness absence among pregnant women. A Cochrane review was found on interventions preventing low back and pelvic pain, and whether treatments decreased the rate of sickness absence, but it focused on randomised controlled trials (RCTs) in prenatal care only.22 Thus, conducting this systematic review is an important contribution to the scientific literature in order to evaluate the effectiveness of interventions to reduce sickness absence in pregnant women in either healthcare settings or workplaces. Results from this systematic review may contribute to developing an evidence-based intervention by integrating factors, processes and stakeholders relevant for preventive initiatives among pregnant women.

Objectives

This systematic review aimed to evaluate the effectiveness of interventions in healthcare settings and workplaces targeting sickness absence among pregnant women.

Methods

Patient and public involvement

Patients were not involved in this review. The electronic databases PubMed, Scopus, CINAHL, PsycINFO, as well as ClinicalTrial.gov and WHO trial registry were searched for published and unpublished studies, respectively. A three-step search strategy was used46 with an initial limited search of PubMed followed by an analysis of the words contained in the title, abstract and index terms. A second search using all identified keywords and index terms was then performed. Finally, the reference lists of all identified studies were searched in order to find additional relevant studies. Studies published in English, Danish, Swedish or Norwegian were included. As the initial search revealed that several studies were published between 1980 and 1990, the databases were searched from January 1980 to April 2017. The following terms were used for the population: pregnant women, pregnancy, gravidity, gestational, child birth, peripartum and perinatal period. For the intervention: rehabilitation, vocational rehabilitation, occupational rehabilitation, intervention, general practitioner, maternal health services, maternal care, perinatal care, antenatal care and workplace intervention. For the outcome: sick leave, sickness absence, return to work, absenteeism, recovery of function, work disability, work capacity evaluation, work retention, health status, occupational diseases, medical leave and medical certificate (see online supplementary appendix A for search strategy).

Criteria for included studies

Population

The population included pregnant women at any gestational age. There were no restrictions based on sociodemographic factors such as age, ethnicity, parity, socioeconomic factors or health-related factors. The population included pregnant women employed in private or public workplaces in all types of work.

Intervention

The review included any intervention targeted at pregnant women. Intervention was defined as any initiative to retain pregnant women. The review compared the effectiveness of interventions carried out in all kinds of workplace settings (workplace or vocational rehabilitation initiatives) or healthcare settings (antenatal care, maternal care services or consultations by general practitioners or midwives). Studies were included regardless of the duration and intensity of the intervention.

Studies

The review included peer-reviewed published and unpublished studies. Study designs included RCTs and quasi-experimental studies with any comparator groups (eg, care as usual, no treatment, second intervention) in order to assess the effectiveness of the interventions.

Outcomes

Only studies assessing sickness absence or absenteeism during pregnancy were included. The occurrence of sickness absence during pregnancy was measured as number of sickness absence episodes and/or length of absence in days/weeks.47

Selection of studies, risk of bias assessment and data extraction

Two reviewers (PP and A-MHM) independently selected studies based on the inclusion criteria. Both reviewers screened the title and abstract of all eligible studies followed by a full-text screening of the selected studies. Any disagreement about selection, assessment and data extraction in included studies would be solved through discussion or by involving a third reviewer. Studies selected for retrieval were assessed prior to inclusion for methodological validity by the two reviewers independently using a standardised critical appraisal instruments from the Joanna Briggs Institute.48 Studies assessed as being of insufficient methodological quality were excluded. Decision rules to be fulfilled for RCTs were all criteria except blinding, while for quasi-experimental studies, they were all criteria except the one concerning multiple measurements of the outcome. The guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses were followed.49 All results were subject to double data entry. The extracted data included specific details regarding the study, settings, participants, description of the interventions, comparators, duration, length of follow-up and outcome measures of significance to the review objective. The authors of the included studies were contacted to request any missing data for clarifying data. If possible the objective was to estimate a summary average of the effect of the interventions concerning the number of days of sickness absence by use of the random-effect model. The improvement was defined as a decrease in sickness absence days at follow-up.

Results

Available evidence

The systematic search identified 1243 potential studies (figure 1), of which nine were quality assessed (table 1). The five included studies were all RCTs from the Scandinavian countries including a single comparison group.50–54
Figure 1

Preferred Reporting Items for Systematic Reviews and Meta-Analyses Flow diagram. Moher et al. 49

Table 1

Quality assessment of studies

Q1Q2Q3Q4Q5Q6Q7Q8Q9Q10Q11Q12Q13
Included studies
 Quality assessment of RCTs
  Elden et al 50 YYYYNYYYYYYYY
  Elden et al 51 YYYNNYYYYYYYY
  Kihlstrand et al 52 YYYNNNAYYYYYYY
  Mørkved et al 53 YYYNNYYYYYYYY
  Stafne et al 54 YYYNNNAYYYYYYY
Excluded studies
 Quality assessment of RCTs
  Ostrgaard et al 55 YNYNNNANNNYYNY
  Granath et al 44 YNYNNUYNYYYYY
 Quality assessment of quasi-experimental studies
  Norèn et al 56 NUUYNYUUN
  Sydsjö et al 45 YYUYNYYYN

Quality assessment of RCTs:

Q1. Was true randomisation used for assignment of participants to treatment groups?

Q2. Was allocation to treatment groups concealed?

Q3. Were treatment groups similar at the baseline?

Q4. Were participants blind to treatment assignment?

Q5. Were those delivering treatment blind to treatment assignment?

Q6. Were outcomes assessors blind to treatment assignment?

Q7. Were treatment groups treated identically other than the intervention of interest?

Q8. Was follow-up complete, and if not, were strategies to address incomplete follow-up used?

Q9. Were participants analysed in the groups to which they were randomised?

Q10. Were outcomes measured in the same way for treatment groups?

Q11. Were outcomes measured in a reliable way?

Q12. Was appropriate statistical analysis used?

Q13. Was the trial design appropriate, and any deviations from the standard RCT design (individual randomisation, parallel groups) accounted for in the conduct and analysis of the trial?

Quality assessment of quasi-experimental studies:

Q1. Is it clear in the study what is the ‘cause’ and what is the ‘effect’ (ie, there is no confusion about which variable comes first)?

Q2. Were the participants included in any comparisons similar?

Q3. Were the participants included in any comparisons receiving similar treatment/care, other than the exposure or intervention of interest?

Q4. Was there a control group?

Q5. Were there multiple measurements of the outcome both pre and post the intervention/exposure?

Q6. Was follow-up complete and if not, were differences between groups in terms of their follow-up adequately described and analysed?

Q7. Were the outcomes of participants included in any comparisons measured in the same way?

Q8. Were outcomes measured in a reliable way?

Q9. Was appropriate statistical analysis used?

N, no; NA, not applicable; RCT, randomised controlled trial; U, unclear; Y, yes.

Quality assessment of studies Quality assessment of RCTs: Q1. Was true randomisation used for assignment of participants to treatment groups? Q2. Was allocation to treatment groups concealed? Q3. Were treatment groups similar at the baseline? Q4. Were participants blind to treatment assignment? Q5. Were those delivering treatment blind to treatment assignment? Q6. Were outcomes assessors blind to treatment assignment? Q7. Were treatment groups treated identically other than the intervention of interest? Q8. Was follow-up complete, and if not, were strategies to address incomplete follow-up used? Q9. Were participants analysed in the groups to which they were randomised? Q10. Were outcomes measured in the same way for treatment groups? Q11. Were outcomes measured in a reliable way? Q12. Was appropriate statistical analysis used? Q13. Was the trial design appropriate, and any deviations from the standard RCT design (individual randomisation, parallel groups) accounted for in the conduct and analysis of the trial? Quality assessment of quasi-experimental studies: Q1. Is it clear in the study what is the ‘cause’ and what is the ‘effect’ (ie, there is no confusion about which variable comes first)? Q2. Were the participants included in any comparisons similar? Q3. Were the participants included in any comparisons receiving similar treatment/care, other than the exposure or intervention of interest? Q4. Was there a control group? Q5. Were there multiple measurements of the outcome both pre and post the intervention/exposure? Q6. Was follow-up complete and if not, were differences between groups in terms of their follow-up adequately described and analysed? Q7. Were the outcomes of participants included in any comparisons measured in the same way? Q8. Were outcomes measured in a reliable way? Q9. Was appropriate statistical analysis used? N, no; NA, not applicable; RCT, randomised controlled trial; U, unclear; Y, yes. Preferred Reporting Items for Systematic Reviews and Meta-Analyses Flow diagram. Moher et al. 49 Table 2 summarises the characteristics and results of the included studies.
Table 2

Characteristics and results from the included studies

Author/year/countryPopulation/ settingIntervention group (IG)Comparison group (CG)OutcomeResults on sickness absence
Elden et al/2008/Sweden50 Healthy women, acupuncture-naive with singleton fetuses, at 12–29 completed gestational weeks. Experiencing evening pain and diagnosed with PGP. n=115 25 antenatal care unitsAcupuncture+standard therapy. 12 acupuncture treatments of 30 min, twice a week for 4 weeks and once a week for 4 weeks. n=58Acupuncture performed as non-penetrating sham+standard therapy. Standard therapy: information from physiotherapist about PGP and anatomy. Elastic pelvic belt, home training programme and leaflet. n=57Sickness absence frequency. Follow-up after 9 weeks (21–28 weeks of gestation).Frequency of women on sickness absence at follow-up—IG 14/58 (24%)—CG 32/57 (56%). No difference was found after adjusting for sickness absence at baseline p=0.14.
Elden et al/2013/Sweden51 Healthy women with singleton fetuses, at 12–29 completed gestational weeks. Experiencing evening pain and diagnosed with PGP. n=123 Hospital, private clinic, 26 antenatal clinicsCraniosacral therapy+standard therapy. 45 min. hands-on-sessions by two experienced therapists. Once weekly for 2 weeks, every second week for 6 weeks (five times). n=63Standard therapy: information from physiotherapist about PGP and anatomy. Elastic pelvic belt and home training programme. Possibility to call any time. n=60Sickness absence frequency. Follow-up after 8 weeks (20–27 weeks of gestation).Frequency of women on sickness absence at follow-up—IG 15/63 (24%)—CG 10/60 (17%) p=0.28
Kihlstrand et al/1999/Sweden52 Women ≥18 years with an expected normal pregnancy and in 15–18 weeks of gestation. n=258 All six antenatal clinics in the region.Water gymnastics, based on a recommended programme: 17–20 times, once a week. 1-hour sessions (30 min physical training, 30 min relaxation in water with music). Led by trained midwife. n=129No intervention. n=129Sickness absence during pregnancy due to back pain. Follow-up at 34 weeks of gestation and 1-week post partum.Frequency of women on sickness absence at any time during follow-up—IG: 16/124 (13%)—CG: 26/120 (22%), p=0.09. Total days on sickness absence—IG: 982—CG:1484.
Mørkved et al/2007/Norway53 Healthy nulliparous women. n=301 Hospital and three outpatient physiotherapy clinics.Aerobic training and pelvic floor muscle exercises. Led by physiotherapist. Group training 1 hour a week for 12 weeks, and daily training at home. General advice related to ergonomics and daily activities. n=148Customary information given by their midwife or GP. n=153Sickness absence due to pelvic girdle or low back pain: ‘Have you been/are you now on sick leave because of pain in the pelvic girdle or lower back?’ Follow-up at 36 weeks of gestation.Women on sickness absence at any time during pregnancy—IG:31/148 (21%)—CG:38/153 (25%), p=0.42.
Stafne et al/2012/Norway54 Women ≥18 years, with a singleton live fetus and 18–22 weeks of gestation. n=855 two hospitals.Exercise programme (aerobic activity, strength training and balance exercise) for 60 min in groups once a week for 12 weeks. Recommended programme, led by physiotherapist, encouraged to do 45 min exercises programme at home twice a week. n=429Standard antenatal care and information from midwife or GP. n=426Prevalence of sickness absence due to LPP. Follow-up at 32–36 weeks of gestation.Women on sickness absence at follow-up—IG: 89/397 (22%)—CG:111/365 (30%). Crude OR for IG was 0.7 (95% CI 0.5 to 0.9). Adjusted OR for baseline values was 0.7 (0.5 to 1.0) p=0.04. Per-protocol analysis included women from IG doing exercise ≥3 days per week. Women on sickness absence at follow-up—IG: 39/216 (18%)—CG: 111/365 (31%). Crude OR for IG was 0.5 (CI 0.3 to 0.8). Adjusted p=0.004.

GP, general practitioner; LPP, lumbopelvic pain; PFM, pelvic floor muscle; PGP, pelvic girdle pain.

Characteristics and results from the included studies GP, general practitioner; LPP, lumbopelvic pain; PFM, pelvic floor muscle; PGP, pelvic girdle pain. A total of four studies were of insufficient methodological quality and thus excluded,44 45 55 56 mainly because allocation to treatment groups was not concealed, follow-up was incomplete, and the statistic test applied was insufficient.

Samples and time period

The total number of women included in the review was 1652 ranging from 123 to 855 women in the individual studies. The populations included healthy pregnant women, however, in two of the studies the women were diagnosed with pelvic girdle pain.50 51 One study was published before 2000,52 two studies between 2000 and 2010,50 53 and two studies after 2010.51 54

Interventions

None of the included studies were performed in a workplace setting. Thus, the included RCTs were all conducted in healthcare settings, that is, antenatal care clinic, physiotherapy clinic or hospital. The providers involved were health professionals, that is, physiotherapists, midwives and general practitioners. The intervention consisted of physical training in three of the five studies. Kihlstrand et al 52 provided physical exercise in water while Mørkved et al 53 and Stafne et al 54 provided a conventional exercise programme. Two of the interventions applied complementary and alternative medicine: craniosacral therapy and acupuncture treatment, respectively.50 51 Kihlstrand et al examined the effect of physical exercise in water compared with no intervention.52 The intervention was provided once a week from 17 to 20 weeks of gestational age consisting of 30 min physical exercise and 30 min of relaxation. Mørkved et al examined the effect of physical training compared with standard information from midwives and general practitioners.53 The programme included 1 hour of aerobic training with a physiotherapist once a week during 12 weeks combined with daily training at home. Stafne et al also examined the effect of exercise compared with standard antenatal care.54 The programme consisted of 1-hour aerobic training with a physiotherapist once a week during 12 weeks; the women were also encouraged to do home exercises twice a week. One study by Elden et al examined the effect of five times craniosacral therapy compared with general information provided by a physiotherapist.51 Another study by the same author examined the effect of 12 acupuncture treatment consultations compared with none-penetrating sham acupuncture.50 In all studies, the intervention was provided face to face; there was no use of telemedicine, for example, mobile phone or email involved. In three studies, the intervention was group based,52–54 otherwise it was individual.50 51

Outcome measures

Sickness absence was reported in different ways. Only one RCT reported sickness absence in days, but did not compare the estimates between the groups.52 Three RCTs reported the frequency of women on sickness absence at the time of follow-up,50 51 54 whereas two RCTs reported the frequency of women who had been on sickness absence at any time during the pregnancy.52 53 Furthermore, overall sickness absence was only measured by Elden et al. 50 51 In the three remaining studies, only sickness absence due to back pain, pelvic girdle or low back pain was measured.52–54 Sickness absence was measured at different follow-up times: between 20 and 28 weeks of gestation50 51 and in three RCTs between 32 and 36 weeks of gestation.52–54

Effectiveness of interventions

The two studies of complementary and alternative medicine found no differences between the groups.50 51 The frequency of sickness absence among pregnant women who received craniosacral therapy at follow-up was 24% compared with 17% of those who received general information (p=0.28),51 and 24% among women receiving acupuncture treatment compared with 56% among women receiving non-penetrating sham acupuncture (p=0.14), respectively.50 Two of the three training interventions demonstrated no effect on sickness absence. A total of 13% of women participating in physical exercise in water were on sickness absence at follow-up compared with 22% in the control group (p=0.09). Pregnant women in the intervention group spent 982 days on sickness absence compared with 1484 days in the control group, but no test for difference was calculated.52 Two studies examined the effect of physical exercise compared with information from midwives and general practitioners.53 54 Mørkved et al found a total of 21% and 25% had been on sickness absence at any time during pregnancy in the intervention group and the control group, respectively (p=0.42). Stafne et al found the exercise programme reduced the frequency of women on sickness absence due to low back pain: 22% in the intervention group versus 30% in the control group (p=0.04), while the frequency was only 18% among the pregnant women who performed the exercise programme three times a week (p=0.004).

Discussion

The aim was to assess the effectiveness of interventions targeting sickness absence; hence the search was limited to experimental studies including a control group. Five RCTs were included in this review, of which all examined interventions delivered in healthcare settings and no intervention was performed at workplaces. Two RCTs examined the effect of complementary and alternative medicine, that is, craniosacral therapy and acupuncture, while three RCTs examined the effect of physical training, that is, exercise in water and a conventional exercise programme. Conducting a statistical meta-analysis was not possible due to heterogeneity of the interventions. Only a 12-week exercise intervention was able to show a significantly lower frequency of women on sickness absence compared with the control group.54 Sickness absence due to low back pain was lower both in the intention-to-treat as well as in the per-protocol analysis, which only included women who had followed the exercise programme minimum three times a week. Kihlstrand et al found a difference in number of women on sickness absence at follow-up between groups.52 However, the estimate was based on a subgroup analysis with a method not well described. In this review, only the results based on the intention-to-treat analysis were presented, therefore, no effect of the study was reported. Moreover, the study by Elden et al found that more pregnant women were employed in regular work after the intervention compared with participants in the control group.50 However, no definition of regular work was stated or how it was measured. The intention of this review was to measure the occurrence of sickness absence during pregnancy measured as length of sickness absence in days or number of episodes. Only Kihlstrand et al measured sickness absence in days, but did not perform a test of difference between the groups.52 All studies analysed the frequency of women on sickness absence, either as a binary outcome at follow-up (yes or no), or sickness absence at any time during the follow-up period. A binary outcome of sickness absence ignores both any information of the length and of previous sickness absence. Therefore, the applied measures may not be suitable to examine a relevant difference between the interventions. The included studies were based on a sample size calculation detecting a difference in a clinical outcome, that is, pain or diabetes. Measuring an occupational outcome require larger study sample size than measuring clinical outcomes only.57 Therefore, the studies may be underpowered and not able to detect a difference in sickness absence. Only the study by Stafne et al was able to detect a difference in frequency of sickness absence. Notably, this study had the largest sample size of the five studies included. The studies by Elden et al 50 51 and Kihlstrand et al 52 found rather large differences between groups, but the differences were not statistical significantly, which may be due to small study populations. It is unclear how the studies have examined sickness absence, as a methodological description of the variable and analysis was lacking. Thus, in most of the studies, it was not stated how the question about sickness absence was phrased, and which statistical method was applied. Furthermore, sickness absence was self-reported, which means that the women had to recall sickness absence days and episodes. Self-reported data may not be as sensitive at detecting an episode of sickness absence as register data collected during several months.58 However, as the follow-up period in the included studies was between 2 and 4 months, it may only have minor influence on the validity. Overall, there is little evidence of interventions to reduce sickness absence performed in healthcare settings, and this review found no interventions performed in workplaces, neither among the four excluded studies. However, a newly registered study is aiming to teach managers how to implement a pregnancy policy.59 In research on vocational rehabilitation, it is well established that interventions including workplaces are the most effective in reducing the duration of overall sickness absence.57 60 This may also apply for pregnant women, but more research is needed to confirm that programmes provided in work place settings reduce sick leave frequency during pregnancy.

Strengths and limitations

This review was based on a systematic search across multiple databases targeting both published and unpublished experimental studies. A quality assessment was performed using a standardised method to ensure only studies of high quality to be included in the review. Only results based on intention-to-treat and per-protocol analysis in the included studies were included in this review, as subgroup analysis may lead to biased results.61 Due to the heterogeneity of the interventions, it was not possible to pool data to perform a statistical meta-analysis. Therefore, the results were only descriptive. It is a limitation that studies included in this review were only conducted in Sweden and Norway which reduces the representativeness. Therefore, the generalisability of the findings to countries with different labour market and social welfare for pregnant women remains unclear. Another limitation is that none of the studies were provided in workplaces.

Future recommendations

It is recommended that future studies in this field will be performed with high quality, for example, power calculation based on sickness absence, transparency of statistical methods and measuring of compliance. First of all, it is important to measure sickness absence based on valid methods, that is, number of days or episodes, and not only as number of individuals on sickness absence. Second, a sample size calculation based on sickness absence should be included. Third, it is highly relevant to test interventions incorporating healthcare settings and the pregnant women’s workplaces. Based on this review, we suggest the effect of interventions including physical activity to be further explored.

Conclusion

The evidence of interventions in healthcare settings and workplaces targeting sickness absence among pregnant women is sparse. The five included studies were all provided in Scandinavian healthcare settings without focus on work maintenance, and no studies were provided in workplaces. Only one study showed a significantly lower frequency of pregnant women on sick leave compared with the control group, which was a 12-week exercise programme delivered by a physiotherapist compared with standard antenatal care. To reduce sickness absence among pregnant women, future interventions including physical activity provided in collaboration with healthcare settings and workplaces are requested. Interventions should measure sickness absence based on valid methods, compliance to the intervention and provide transparency of statistical methods.
  49 in total

1.  Symptoms during normal pregnancy: a prospective controlled study.

Authors:  M Zib; L Lim; W A Walters
Journal:  Aust N Z J Obstet Gynaecol       Date:  1999-11       Impact factor: 2.100

2.  Reduction of sick leave for lumbar back and posterior pelvic pain in pregnancy.

Authors:  L Norén; S Ostgaard; T F Nielsen; H C Ostgaard
Journal:  Spine (Phila Pa 1976)       Date:  1997-09-15       Impact factor: 3.468

3.  Insomnia and depressive symptoms in late pregnancy: a population-based study.

Authors:  Signe K Dørheim; Bjørn Bjorvatn; Malin Eberhard-Gran
Journal:  Behav Sleep Med       Date:  2012       Impact factor: 2.964

4.  Water-gymnastics reduced the intensity of back/low back pain in pregnant women.

Authors:  M Kihlstrand; B Stenman; S Nilsson; O Axelsson
Journal:  Acta Obstet Gynecol Scand       Date:  1999-03       Impact factor: 3.636

Review 5.  Work activities and risk of prematurity, low birth weight and pre-eclampsia: an updated review with meta-analysis.

Authors:  Keith T Palmer; Matteo Bonzini; E Clare Harris; Cathy Linaker; Jens Peter Bonde
Journal:  Occup Environ Med       Date:  2013-01-23       Impact factor: 4.402

6.  Does group training during pregnancy prevent lumbopelvic pain? A randomized clinical trial.

Authors:  Siv Mørkved; Kjell Asmund Salvesen; Berit Schei; Stian Lydersen; Kari Bø
Journal:  Acta Obstet Gynecol Scand       Date:  2007       Impact factor: 3.636

7.  Effects of craniosacral therapy as adjunct to standard treatment for pelvic girdle pain in pregnant women: a multicenter, single blind, randomized controlled trial.

Authors:  Helen Elden; Hans-Christian Östgaard; Anna Glantz; Pia Marciniak; Ann-Charlotte Linnér; Monika Fagevik Olsén
Journal:  Acta Obstet Gynecol Scand       Date:  2013-03-04       Impact factor: 3.636

8.  Sick leave during pregnancy: a longitudinal study of rates and risk factors in a Norwegian population.

Authors:  S K Dørheim; B Bjorvatn; M Eberhard-Gran
Journal:  BJOG       Date:  2012-11-07       Impact factor: 6.531

Review 9.  Pregnancy: occupational aspects of management: concise guidance.

Authors:  Keith T Palmer; Matteo Bonzini; Jens-Peter Ellekilde Bonde
Journal:  Clin Med (Lond)       Date:  2013-02       Impact factor: 2.659

10.  Effects of a weight-gain restriction programme for obese pregnant women on sickness absence and pregnancy benefits.

Authors:  Gunilla Sydsjö; Wiktor Gustafsson Monfils; Nicholas de Keyser; Ing-Marie Claesson; Adam Sydsjö; Ann Josefsson
Journal:  Scand J Prim Health Care       Date:  2013-01-10       Impact factor: 2.581

View more
  1 in total

1.  Reflections on workplace adjustments for pregnant employees: a qualitative study of the experiences of pregnant employees and their managers.

Authors:  Dorte Raaby Andersen; Anne-Mette Hedeager Momsen; Pernille Pedersen; Rikke Damkjær Maimburg
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-01       Impact factor: 3.105

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.